Clinical trial
Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of…
NCT00251355 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00251355 |
|---|---|
| Title | Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer |
| Official title | A Phase I Study of Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Locally Unresectable Non-Metastatic Pancreatic Cancer |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital Massachusetts General Hospital |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Gemcitabine, 5-Fluorouracil, Radiation Therapy |
| Enrollment | 40 |
| Start date | Jan 1, 1998 |
| Primary completion | Jun 1, 2007 |
| Completion | Aug 1, 2008 |
| First posted | Nov 10, 2005 |
| Last update posted | Dec 20, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: